Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphism of Baculoviral Inhibitor of Apoptosis Repeat-Containing 5 (BIRC5) Can Be Associated with Clinical Outcome of Non-Small Cell Lung Cancer.

Cells - 10 Mar 2022

Szczyrek Michał, Mlak Radosław, Szudy-Szczyrek Aneta, Wojas-Krawczyk Kamila, Kędziora Karolina, Milanowski Janusz

Abstract excerpt

Non-small cell lung cancer (NSCLC) comprises about 85% of all lung cancers. Currently, NSCLC therapy is based on the analysis of specific predictors, whose presence qualifies patients for appropriate treatment. Baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5), also known as "survivin", is a protein whose expression is characteristic for most malignant tumors and fetal tissue, while absent in mature...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inhibitor of Apoptosis Proteins

Share to Lung Neoplasms

Share to Polymorphism, Single Nucleotide

Share to Survivin

Source

Open in PubMed Open full text

Identifiers

PMID: 35326407
DOI: 10.3390/cells11060956
PMCID: PMC8946487

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphism of Baculoviral Inhibitor of Apoptosis Repeat-Containing 5 (BIRC5) Can Be Associated with Clinical Outcome of Non-Small Cell Lung Cancer.PMID 35326407Read ↗

Comprehensive analysis of BIRC5: from pan-cancer analysis to experimental validation.Semantic proximity Read ↗

BIRC5 Inhibition Is Associated with Pyroptotic Cell Death via Caspase3-GSDME Pathway in Lung Adenocarcinoma CellsSemantic proximity Read ↗

Functional polymorphism -31C/G in the promoter of BIRC5 gene and risk of nasopharyngeal carcinoma among chinese.Semantic proximity Read ↗

Association between survivin gene Polymorphism -31G/C and Risk of Lung and Gastrointestinal cancers : A Systematic Review and Meta-AnalysisSemantic proximity Read ↗

An Insight into Survivin in Relevance to Hematological, Biochemical and Genetic Characteristics in Tobacco Chewers with Oral Squamous Cell Carcinoma.Semantic proximity Read ↗

Survivin (BIRC5): Implications in cancer therapySemantic proximity Read ↗

Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics AnalysisSemantic proximity Read ↗

Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival.Semantic proximity Read ↗

A comprehensive review and in silico analysis of the role of survivin (BIRC5) in hepatocellular carcinoma hallmarks: A step toward precisionSemantic proximity Read ↗

Implication of BIRC5 in asthma pathogenesis.Semantic proximity Read ↗

A candidate single nucleotide polymorphism in the 3' untranslated region (rs17878624) of survivin gene for NSCLC.Semantic proximity Read ↗

Genetic variation in a miR-335 binding site in BIRC5 alters susceptibility to lung cancer in Chinese Han populations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.